Peer-Reviewed Technical Note: Influence of Common Excipients on the Crystalline Modification of Freeze-Dried Mannitol - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Peer-Reviewed Technical Note: Influence of Common Excipients on the Crystalline Modification of Freeze-Dried Mannitol


Pharmaceutical Technology
Volume 3, Issue 32

References

1. M. J. Pikal, "Freeze Drying," Encyclopedia of Pharmaceutical Technology (Marcel Dekker, New York, 2002), pp. 1299–1326.

2. R.K. Cavatur et al., "Crystallization Behavior of Mannitol in Frozen Aqueous Solutions," Pharm. Res. 19 (6), 894–900 (2002).

3. X. Liao et al., "Influence of Processing Conditions on the Physical State of Mannitol—Implications in Freeze-Drying," Pharm. Res. 24 (2), 370–376 (2007).

4. A.I. Kim et al., "The Physical State of Mannitol after Freeze-Drying: Effects of Mannitol Concentration, Freezing Rate, and a NonCrystallizing Cosolute," J. Pharm. Sci., 87 (8), 931–935 (1998).

5. A. Burger et al., "Energy/Temperature Diagram and Compression Behavior of the Polymorphs of D-Mannitol," J. Pharm. Sci. 89 (4), 457–468 (2000).

6. C. Telang et al., "Crystallization of D-Mannitol in Binary Mixtures with NaCl: Phase Diagram and Polymorphism," Pharm. Res. 20 (12), 1939–1945 (2003).

7. J. Liu, "Physical Characterization of Pharmaceutical Formulations in Frozen and Freeze-Dried Solid States: Techniques and Applications in Freeze-Drying Development," Pharm. Dev. Technol. 11 (1), 3–38 (2006).

8. K. Chatterjee et al., "Partially Crystalline Systems in Lyophilization: II. Withstanding Collapse at High Primary Drying Temperatures and Impact on Protein Activity Recovery," J. Pharm. Sci. 94 (4), 809–820 (2005).

9. T. Yoshinari et al., "Moisture Induced Polymorphic Transition of Mannitol and its Morphological Transformation," Int. J. Pharm. 247 (1–2), 69–77 (2002).

10. L. Yu et al., "Existence of a Mannitol Hydrate During Freeze-Drying and Practical Implications," J. Pharm. Sci. 88 (2), 196-198(1999).

11. A. Hawe and W. Friess, "Impact of Freezing Procedure and Annealing on the Physico-Chemical Properties and the Formation of Mannitol Hydrate in Mannitol-Sucrose-NaCl Formulations," Eur J Pharm Biopharm 64 (3), 316–325 (2006).

12. L. Yu et al., "Determination of the Glass Properties of D-Mannitol Using Sorbitol as an Impurity," J. Pharm. Sci. 87 (6), 774–777 (1998).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here